ANTIARRHYTHMIC EFFECTS OF RANOLAZINE IN PATIENTS WITH CARDIAC ARRHYTHMIAS

Ranolazine (R) is approved for the management of chronic angina. R has been found to have multichannel blocking effects including the cardiac late sodium current, as well as inhibition of the rapid delayed-rectifier potassium current, which leads to an increased QT interval in a dose-related manner